HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity

Files in This Item:

The file(s) associated with this item can be obtained from the following URL: https://doi.org/10.1016/j.ctro.2022.05.004


Title: A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity
Authors: Uchinami, Yusuke Browse this author
Katoh, Norio Browse this author →KAKEN DB
Suzuki, Ryusuke Browse this author
Kanehira, Takahiro Browse this author
Tamura, Masaya Browse this author
Takao, Seishin Browse this author
Matsuura, Taeko Browse this author
Miyamoto, Naoki Browse this author
Fujita, Yoshihiro Browse this author
Koizumi, Fuki Browse this author
Taguchi, Hiroshi Browse this author
Yasuda, Koichi Browse this author
Nishioka, Kentaro Browse this author
Yokota, Isao Browse this author
Kobashi, Keiji Browse this author
Aoyama, Hidefumi Browse this author →KAKEN DB
Keywords: Primary liver tumors
NTCP model
Model-based selection
Issue Date: Jul-2022
Publisher: Elsevier
Journal Title: Clinical and Translational Radiation Oncology
Volume: 35
Start Page: 70
End Page: 75
Publisher DOI: 10.1016/j.ctro.2022.05.004
Abstract: Background: For small primary liver tumors, favorable outcomes have been reported with both of proton beam therapy (PBT) and X-ray therapy (XRT). However, no clear criteria have been proposed in the cases for which and when of PBT or XRT has to be used. The aim of this study is to investigate cases that would benefit from PBT based on the predicted rate of hepatic toxicity. Materials and methods: Eligible patients were those who underwent PBT for primary liver tumors with a maximum diameter of <= 5 cm and Child-Pugh grade A (n = 40). To compare the PBT-plan, the treatment plan using volumetric modulated arc therapy was generated as the XRT-plan. The rate of predicted hepatic toxicity was estimated using five normal tissue complication probability (NTCP) models with three different endpoints. The differences in NTCP values (Delta NTCP) were calculated to determine the relative advantage of PBT. Factors predicting benefits of PBT were analyzed by logistic regression analysis. Results: From the dose-volume histogram comparisons, an advantage of PBT was found in sparing of the normal liver receiving low doses. The factors predicting the benefit of PBT differed depending on the selected NTCP model. From the five models, the total tumor diameter (sum of the target tumors), location (hepatic hilum vs other), and number of tumors (1 vs 2) were significant factors. Conclusions: From the radiation-related hepatic toxicity, factors were identified to predict benefits of PBT in primary liver tumors with Child-Pugh grade A, with the maximum tumor diameter of <= 5 cm.
Type: article
URI: http://hdl.handle.net/2115/86289
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University